Aggressive Anticoagulation after TJA: an evaluation of the ACCP guidelines for Thromboprophylaxis

Javad Parvizi1, Lauren K Kahl, Chelsea Dalsey

  • 1Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. parvj@aol.com

Insights

Orthopaedic surgery patients face high risks of thromboembolic disease. The American Association of Orthopaedic Surgeons (AAOS) guidelines offer a safer thromboprophylaxis approach by considering anticoagulation risks, unlike the American College of Chest Physicians (ACCP) guidelines.

Area of Science:

  • Orthopaedic Surgery
  • Thromboprophylaxis
  • Anticoagulation Therapy

Background:

  • Thromboembolic disease, including pulmonary embolism and deep vein thrombosis (DVT), is a significant concern following orthopaedic surgery.
  • Anticoagulant administration is a common strategy to mitigate these risks, with established guidelines from professional organizations.
  • Current guidelines from the American College of Chest Physicians (ACCP) and the American Association of Orthopaedic Surgeons (AAOS) offer differing recommendations for antithrombotic protocols.

Purpose of the Study:

  • To compare the American College of Chest Physicians (ACCP) and American Association of Orthopaedic Surgeons (AAOS) guidelines for thromboprophylaxis after orthopaedic surgery.
  • To evaluate the potential complications associated with aggressive anticoagulation regimens recommended by the ACCP.
  • To advocate for the AAOS guidelines as a potentially safer alternative for patients undergoing orthopaedic procedures.

Main Methods:

  • Review and comparison of existing ACCP and AAOS guidelines on antithrombotic therapy post-orthopaedic surgery.
  • Analysis of potential complications associated with ACCP-recommended anticoagulation, such as bleeding events, thrombocytopenia, and infection.
  • Evaluation of the AAOS guideline's approach, including the use of aspirin, mechanical compression, and low-dose warfarin.

Main Results:

  • The ACCP guidelines are considered potentially excessive and may not fully account for anticoagulation-related complications.
  • The AAOS guidelines focus on preventing pulmonary embolism and consider a broader range of risks, including bleeding and infection.
  • The AAOS guidelines permit the use of aspirin with mechanical compression devices and low-dose warfarin, offering alternative thromboprophylaxis strategies.

Conclusions:

  • The ACCP guidelines may lead to significant complications due to aggressive anticoagulation.
  • The AAOS guidelines provide a more balanced approach to thromboprophylaxis, considering patient safety and potential adverse events.
  • The AAOS guidelines represent a potentially safer option for managing thromboembolic risk in orthopaedic surgery patients.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...